Regulation of neuropeptide mRNA expression in the basal ganglia by intrastriatal and intranigral transplants in the rat Parkinson model

Neuroscience

Volumn 118, Issue 4, 2003, Pages 1063-1077

  Winkler, C ^a,b   Bentlage, C ^a   Cenci, M A ^a   Nikkhah, G ^c   Bjorklund A ^a  

^a LUND UNIVERSITY   (Sweden)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

D2 receptor; GABA; GAD; Preproenkephalin; Preprotachykinin; Transplantation

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE 2 RECEPTOR; GLUTAMATE DECARBOXYLASE; MESSENGER RNA; NEUROPEPTIDE; PREPROENKEPHALIN; PREPROTACHYKININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DOWN REGULATION; FETAL TISSUE TRANSPLANTATION; LOCOMOTION; MESENCEPHALON; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REINNERVATION; STRIATE CORTEX; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION; UPREGULATION;

EID: 0037728902     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00007-1     Document Type: Article

References (72)

1. Abrous D.N., Shaltot A.R., Torres E.M., Dunnett S.B. Dopamine-rich grafts in the neostriatum and/or nucleus accumbens effects on drug-induced behaviours and skilled paw-reaching . Neuroscience. 53:1993;187-197.
2. Aubert I., Ghorayeb I., Normand E., Bloch B. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. J Comp Neurol. 418:2000;22-32.
3. Bal A., Savasta M., Chritin M., Mennicken F., Abrous D.N., Le Moal M., Feuerstein C., Herman J.P. Transplantation of fetal nigral cells reverses the increase of preproenkephalin mRNA levels in the rat striatum caused by 6-OHDA lesion of the dopaminergic nigrostriatal pathway a quantitative in situ hybridization study . Brain Res Mol Brain Res. 18:1993;221-227.
4. Bezard E., Ravenscroft P., Gross C.E., Crossman A.R., Brotchie J.M. Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Neurobiol Dis. 8:2001;343-350.
5. Björklund A. Dopaminergic transplants in experimental parkinsonism cellular mechanisms of graft-induced functional recovery . Curr Opin Neurobiol. 2:1992;683-689.
6. Björklund A., Dunnett S.B., Nikkhah G. Nigral transplants in the rat Parkinson model functional limitations and strategies to enhance nigrostriatal reconstruction . Dunnett S.B., Björklund A. Functional neural transplantation. 1994;47-68 Raven Press, New York.
7. Blunt S.B., Jenner P., Marsden C.D. Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopa. Brain Res. 582:1992;299-311.
8. Brecknell J.E., Du J.S., Muir E., Fidler P.S., Hlavin M.L., Dunnett S.B., Fawcett J.W. Bridge grafts of fibroblast growth factor-4-secreting schwannoma cells promote functional axonal regeneration in the nigrostriatal pathway of the adult rat. Neuroscience. 74:1996;775-784.
9. Bunzow J.R., Van Tol H.H., Grandy D.K., Albert P., Salon J., Christie M., Machida C.A., Neve K.A., Civelli O. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature. 336:1988;783-787.
10. Cadet J.L., Zhu S.M., Angulo J.A. Intrastriatal implants of fetal mesencephalic cells attenuate the increases in striatal proenkephalin mRNA observed after unilateral 6-hydroxydopamine-induced lesions of the striatum. Brain Res Bull. 27:1991;707-711.
11. Capozzo A., Florio T., Di Loreto S., Adorno D., Scarnati E. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat. II. Effects on corticostriatal transmission. Exp Neurol. 146:1997;142-150.
12. Cenci M.A., Campbell K., Björklund A. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels . Neuroscience. 57:1993;275-296.
13. Cenci M.A., Kalen P., Duan W.-M., Bjorklund A. Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens effects of pharmacological and behavioral stimuli . Brain Res. 641:1994;225-248.
14. Cenci M.A., Campbell K., Björklund A. Glutamic acid decarboxylase gene expression in the dopamine-denervated striatum effects of intrastriatal fetal nigral transplants or chronic apomorphine treatment . Brain Res Mol Brain Res. 48:1997;149-155.
15. Chritin M., Savasta M., Mennicken F., Bal A., Abrous D.N., Le M.M., Feuerstein C., Herman J.P. Intrastriatal dopamine-rich implants reverse the increase of dopamine D-2 receptor mRNA levels caused by lesion of the nigrostriatal pathway a quantitative in situ hybridization study . Eur J Neurosci. 4:1992;663-672.
16. Clarke D.J., Brundin P., Strecker R.E., Nilsson O.G., Björklund A., Lindvall O. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry . Exp Brain Res. 73:1988;115-126.
17. Di Loreto S., Florio T., Capozzo A., Napolitano A., Adorno D., Scarnati E. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat. I. Effects on spontaneous activity of striatal neurons. Exp Neurol. 138:1996;318-326.
18. Doucet G., Murata Y., Brundin P., Bosler O., Mons N., Geffard M., Ouimet C.C., Björklund A. Host afferents into intrastriatal transplants of fetal ventral mesencephalon. Exp Neurol. 106:1989;1-19.
19. Dunnett S.B., Whishaw I.Q., Rogers D.C., Jones G.H. Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions. Brain Res. 415:1987;63-78.
20. Engber T.M., Boldry R.C., Kuo S., Chase T.N. Dopaminergic modulation of striatal neuropeptides differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin . Brain Res. 581:1992;261-268.
21. Fisher L.J., Young S.J., Tepper J.M., Groves P.M., Gage F.H. Electrophysiological characteristics of cells within mesencephalon suspension grafts. Neuroscience. 40:1991;109-122.
22. Freund T.F., Bolam J.P., Björklund A., Stenevi U., Dunnett S.B., Powell J.F., Smith A.D. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum a tyrosine hydroxylase immunocytochemical study . J Neurosci. 5:1985;603-616.
23. Gagnon C., Bedard P.J., Rioux L., Gaudin D., Martinoli M.G., Pelletier G., Di Paolo T. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat. Brain Res. 558:1991;251-263.
24. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
25. Gerfen C.R., McGinty J.F., Young W.S.I. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons in situ hybridization histochemical analysis . J Neurosci. 11:1991;1016-1031.
26. Gerfen C.R. The neostriatal mosaic multiple levels of compartmental organization . Trends Neurosci. 15:1992;133-139.
27. Goodman R.H., Aron D.C., Roos B.A. Rat pre-prosomatostatin structure and processing by microsomal membranes . J Biol Chem. 258:1983;5570-5573.
28. Herman J.P., Choulli K., Geffard M., Nadaud D., Taghzouti K., Le Moal M. Reinnervation of the nucleus accumbens and frontal cortex of the rat by dopaminergic grafts and effects on hoarding behavior. Brain Res. 372:1986;210-216.
29. Herman J.P., Abrous N.D. Dopaminergic neural grafts after fifteen years results and perspectives . Prog Neurobiol. 44:1994;1-35.
30. Howells R.D., Kilpatrick D.L., Bhatt R., Monahan J.J., Poonian M., Udenfriend S. Molecular cloning and sequence determination of rat preproenkephalin cDNA sensitive probe for studying transcriptional changes in rat tissues . Proc Natl Acad Sci USA. 81:1984;7651-7655.
31. Hudson J.L., Bickford P., Johansson M., Hoffer B.J., Strömberg I. Target and neurotransmitter specificity of fetal central nervous system transplants importance for functional reinnervation . J Neurosci. 14:1994;283-290.
32. Kirik D., Winkler C., Björklund A. Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J Neurosci. 21:2001;2889-2896.
33. Kobayashi Y., Kaufman D.L., Tobin A.J. Glutamic acid decarboxylase cDNA nucleotide sequence encoding an enzymatically active fusion protein . J Neurosci. 7:1987;2768-2772.
34. Krause J.E., Chirgwin J.M., Carter M.S., Xu Z.S., Hershey A.D. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc Natl Acad Sci USA. 84:1987;881-885.
35. Lindvall O. Neural transplantation a hope for patients with Parkinson's disease . Neuroreport. 8:1997;iii-x.
36. Mahalik T.J., Finger T.E., Strömberg I., Olson L. Substantia nigra transplants into denervated striatum of the rat ultrastructure of graft and host interconnections . J Comp Neurol. 240:1985;60-70.
37. Mandel R.J., Brundin P., Björklund A. The importance of graft placement and task complexity for transplant-induced recovery of simple and complex sensorimotor deficits in dopamine denervated rats. Eur J Neurosci. 2:1990;888-894.
38. Maneuf Y.P., Mitchell I.J., Crossman A.R., Brotchie J.M. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus. Exp Neurol. 125:1994;65-71.
39. Mendez I., Elisevich K., Flumerfelt B. Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts an ultrastructural double-labeling immunocytochemical study . J Comp Neurol. 308:1991;66-78.
40. Mendez I.M., Naus C.C., Elisevich K., Flumerfelt B.A. Normalization of striatal proenkephalin and preprotachykinin mRNA expression by fetal substantia nigra grafts. Exp Neurol. 119:1993;1-10.
41. Montoya C.P., Astell S., Dunnett S.B. Effects of nigral and striatal grafts on skilled forelimb use in the rat. Prog Brain Res. 82:1990;459-466.
42. Montoya C.P., Campbell-Hope L.J., Pemberton K.D., Dunnett S.B. The "staircase test:" a measure of independent forelimb reaching and grasping abilities in rats . J Neurosci Methods. 36:1991;219-228.
43. Mukhida K., Baker K.A., Sadi D., Mendez I. Enhancement of sensorimotor behavioral recovery in hemiparkinsonian rats with intrastriatal, intranigral and intrasubthalamic nucleus dopaminergic transplants. J Neurosci. 21:2001;3521-3530.
44. Nakao N., Ogura M., Nakai K., Itakura T. Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease. J Neurosci. 18:1998;1806-1817.
45. Nikkhah G., Duan W.M., Knappe U., Jödicke A., Björklund A. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model. Neuroscience. 56:1993;33-43.
46. Nikkhah G., Bentlage C., Cunningham M.G., Björklund A. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J Neurosci. 14:1994;3449-3461.
47. Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M.G., Björklund A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model a detailed account of the methodology . Neuroscience. 63:1994;57-72.
48. Nikkhah G., Winkler C., Rödter A., Samii M. Microtransplantation of nigral dopamine neurons a step-by-step recipe . Dunnett S.B., Boulton A.A., Baker G.B. Neuromethods: cell and tissue transplantation in the CNS. 2000;207-231 The Human Press, Totowa.
49. Nisenbaum L.K., Kitai S.T., Gerfen C.R. Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation effects of systemic and central administration of quinpirole and scopolamine . Neuroscience. 63:1994;435-449.
50. Olsson M., Nikkhah G., Bentlage C., Björklund A. Forelimb akinesia in the rat Parkinson model differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test . J Neurosci. 15:1995;3863-3875.
51. Palmer M.R., Granholm A.C., van Horne C.G., Giardina K.E., Freund R.K., Moorhead J.W., Gerhardt G.A. Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats. Brain Res. 890:2001;86-99.
52. Rajakumar N., Rushlow W., Rajakumar B., Naus C.C., Stoessl A.J., Flumerfelt B.A. Effects of graft-derived dopaminergic innervation on the target neurons of patch and matrix compartments of the striatum. Neuroscience. 76:1997;1173-1185.
53. Robertson H.A. Dopamine receptor interactions some implications for the treatment of Parkinson's disease . Trends Neurosci. 15:1992;201-206.
54. Savasta M., Mennicken F., Chritin M., Abrous D.N., Feuerstein C., Le Moal M., Herman J.P. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats an autoradiographic study . Neuroscience. 46:1992;729-738.
55. Schallert T., Hall S. 'Disengage' sensorimotor deficit following apparent recovery from unilateral dopamine depletion. Behav Brain Res. 30:1988;15-24.
56. Schallert T., Norton D., Jones T.A. A clinically relevant unilateral rat model of Parkinsonian akinesia. J Neural Transplant Plast. 3:1992;332-333.
57. Schneider J.S., Decamp E., Wade T. Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology . J Neurosci. 19:1999;6643-6649.
58. Segovia J., Castro R., Notario V., Gale K. Transplants of fetal substantia nigra regulate glutamic acid decarboxylase gene expression in host striatal neurons. Brain Res Mol Brain Res. 10:1991;359-362.
59. Sirinathsinghji D.J., Dunnett S.B. Increased proenkephalin mRNA levels in the rat neostriatum following lesion of the ipsilateral nigrostriatal dopamine pathway with 1-methyl-4-phenylpyridinium ion (MPP+) reversal by embryonic nigral dopamine grafts . Mol Brain Res. 9:1991;263-269.
60. Smith Y., Shink E., Sidibe M. Neuronal circuitry and synaptic connectivity of the basal ganglia. Neurosurg Clin N Am. 9:1998;203-222.
61. Soghomonian J.J., Chesselet M.F. Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rat. Neuroscience. 42:1991;49-59.
62. Strömberg I., Johnson S., Hoffer B., Olson L. Reinnervation of dopamine-denervated striatum by substantia nigra transplants immunohistochemical and electrophysiological correlates . Neuroscience. 14:1985;981-990.
63. Strömberg I., Bickford P. Reduced ageing effects of striatal neuronal discharge rate by aged ventral mesencephalic grafts. Neuroreport. 7:1996;693-696.
64. Vuillet J., Moukhles H., Nieoullon A., Daszuta A. Ultrastructural analysis of graft-to-host connections, with special reference to dopamine-neuropeptide Y interactions in the rat striatum, after transplantation of fetal mesencephalon cells. Exp Brain Res. 98:1994;84-96.
65. Wade T.V., Schneider J.S. Expression of striatal preprotachykinin mRNA in symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys is related to parkinsonian motor signs. J Neurosci. 21:2001;4901-4907.
66. Wictorin K., Ouimet C.C., Björklund A. Intrinsic organization and connectivity of intrastriatal striatal transplants in rats as revealed by DARPP-32 immunohistochemistry specificity of connections with the lesioned host brain . Eur J Neurosci. 1:1989;690-701.
67. Wilby M.J., Sinclair S.R., Muir E.M., Zietlow R., Adcock K.H., Horellou P., Rogers J.H., Dunnett S.B., Fawcett J.W. A glial cell line-derived neurotrophic factor-secreting clone of the Schwann cell line SCTM41 enhances survival and fiber outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra. J Neurosci. 19:1999;2301-2312.
68. Winkler C., Sauer H., Lee C.S., Björklund A. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci. 16:1996;7206-7215.
69. Winkler C., Bentlage C., Nikkhah G., Samii M., Björklund A. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp Neurol. 155:1999;165-186.
70. Winkler C., Kirik D., Björklund A., Dunnett S.B. Transplantation in the rat model of Parkinson's disease ectopic versus homotopic graft placement . Prog Brain Res. 127:2000;233-265.
71. Yurek D.M. Intranigral transplants of fetal ventral mesencephalic tissue attenuate D1-agonist-induced rotational behavior. Exp Neurol. 143:1997;1-9.
72. Zeng B.Y., Jenner P., Marsden C.D. Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery. Mov Disord. 11:1996;43-52.